Annalisa Marinosci

6PUBLICATIONS
34CO-AUTHORS
Immunogenetics (incl. genetic immunology)PharmacogenomicsSocial epidemiologyAutoimmunityBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 12, 2026
Switching to Integrase Inhibitors and Cardiovascular Disease Risk in Treatment-Experienced People With HIV: A Sequential Target Trial Emulation in the Swiss HIV Cohort Study.

|Aug 12, 2026
Sustained Virologic Suppression After Discontinuation of Long-acting Cabotegravir/Rilpivirine: A Two-case Series Highlighting Unexpected Heterogeneity in Pharmacokinetics and Viral Control.

|Jan 08, 2026
Association of leukocyte count with death in people with HIV: A longitudinal study over 24 years.

Zoe Klein, Sophia C Meyer, Isabella C Schoepf

|Jul 23, 2025
Types of Myocardial Infarction in People With HIV in Switzerland.

Julia N Kleynhans, Naomi N Cobo, Emma F Avery

|Nov 07, 2024
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.

Annalisa Marinosci, Delphine Sculier, Gilles Wandeler

|Nov 10, 2020
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.

Delphine Sculier, Gilles Wandeler, Sabine Yerly

Pageof 1

Frequent Collaborators

4 joint publications

Matthias Cavassini

4 joint publications

Huldrych F Günthard

3 joint publications

Enos Bernasconi

2 joint publications

Christian R Kahlert